Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2023-01-26 00:00:00 ET · period of report 2023-01-24 · accession 0001209191-23-005031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-26 | 2023-01-24 | TVTX | Heerma Peter | Chief Commercial Off | S - Sale | $21.90 | -1,550 | 63.6K | -2% | -$33.9K |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-24 | S | D | 1,550 | $21.90 | 63,598 | D | — | — |